Required for Their Activation Survival of Anergic Anti-DNA B Cells , Yet Is TLR 9 Promotes Tolerance by Restricting Shlomchik
暂无分享,去创建一个
[1] E. L. Luning Prak,et al. B-Cell Tolerance Defects in the B6.Aec1/2 Mouse Model of Sjögren’s Syndrome , 2012, Journal of Clinical Immunology.
[2] Idan Tamir,et al. Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. , 2011, Immunity.
[3] H. Wardemann,et al. AutoimmunityTo Control Th17 Cells and Severe Production of Protective Self-Reactive IgM TLR9 in Peritoneal B-1b Cells Is Essential for , 2011 .
[4] Sarah E. Ewald,et al. Nucleic acid recognition by the innate immune system. , 2011, Annual review of immunology.
[5] S. Akira,et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. , 2010, Journal of autoimmunity.
[6] W. Thomas,et al. Absence of SHIP-1 Results in Constitutive Phosphorylation of Tank-Binding Kinase 1 and Enhanced TLR3-Dependent IFN-β Production , 2010, The Journal of Immunology.
[7] J. Shupe,et al. TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus , 2010, The Journal of Immunology.
[8] M. Rickels,et al. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes , 2008, The Journal of experimental medicine.
[9] J. Casanova,et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. , 2008, Immunity.
[10] Uri Hershberg,et al. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. , 2008, Immunity.
[11] S. Gauld,et al. B-cell anergy: from transgenic models to naturally occurring anergic B cells? , 2007, Nature Reviews Immunology.
[12] D. Melamed,et al. CpG DNA stimulates autoreactive immature B cells in the bone marrow , 2007, European journal of immunology.
[13] M. Shlomchik,et al. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. , 2007, Seminars in immunology.
[14] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[15] J. Shupe,et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.
[16] T. Winkler,et al. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. , 2006, International immunology.
[17] P. Courville,et al. Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus1 , 2006, The Journal of Immunology.
[18] E. L. Prak,et al. Exogenous and Endogenous TLR Ligands Activate Anti-Chromatin and Polyreactive B Cells1 , 2006, The Journal of Immunology.
[19] J. Erikson,et al. The regulation and activation of lupus‐associated B cells , 2005, Immunological reviews.
[20] J. Cyster,et al. Requirements for Follicular Exclusion and Competitive Elimination of Autoantigen-Binding B Cells1 , 2004, The Journal of Immunology.
[21] Yoram Louzoun,et al. Editing Anti-DNA B Cells by Vλx , 2004, The Journal of experimental medicine.
[22] T. Manser,et al. Progressive Surface B Cell Antigen Receptor Down-Regulation Accompanies Efficient Development of Antinuclear Antigen B Cells to Mature, Follicular Phenotype1 , 2004, The Journal of Immunology.
[23] F. Finkelman,et al. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. , 2002, Immunity.
[24] M. Madaio,et al. Fas/Fas Ligand Deficiency Results in Altered Localization of Anti-Double-Stranded DNA B Cells and Dendritic Cells1 , 2001, The Journal of Immunology.
[25] R. Hardy,et al. Functional Consequences of the Developmental Arrest and Follicular Exclusion of Anti-Double-Stranded DNA B Cells1 , 2000, The Journal of Immunology.
[26] C. Sokol,et al. MRL-lpr/lpr Mice Exhibit a Defect in Maintaining Developmental Arrest and Follicular Exclusion of Anti–double-stranded DNA B Cells , 1999, The Journal of experimental medicine.
[27] J. Allison,et al. Repression of B7.2 on Self-reactive B Cells Is Essential to Prevent Proliferation and Allow Fas-mediated Deletion by CD4+ T Cells , 1998, The Journal of experimental medicine.
[28] M. Shlomchik,et al. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease , 1996, The Journal of experimental medicine.
[29] J. Cyster,et al. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. , 1995, Immunity.
[30] M. Radic,et al. Light chain contribution to specificity in anti-DNA antibodies. , 1995, Journal of immunology.
[31] C. Kuntz,et al. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus , 1995, The Journal of experimental medicine.
[32] R. Hardy,et al. The site and stage of anti-DNA B-cell deletion , 1995, Nature.
[33] R. Hardy,et al. Deletion and editing of B cells that express antibodies to DNA. , 1994, Journal of immunology.
[34] M. Cancro,et al. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. , 1993, Journal of immunology.
[35] W. Anderson,et al. Residues that mediate DNA binding of autoimmune antibodies. , 1993, Journal of immunology.
[36] S. Camper,et al. Receptor editing: an approach by autoreactive B cells to escape tolerance , 1993, The Journal of experimental medicine.
[37] M. Monestier,et al. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. , 1992, Journal of immunology.
[38] R. Hardy,et al. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice , 1991, Nature.
[39] D. Pisetsky,et al. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation , 1990, The Journal of experimental medicine.
[40] D. Pisetsky,et al. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Bouvet,et al. Restricted heterogeneity of polyclonal rheumatoid factors. , 1987, Arthritis & Rheumatism.
[42] D. Melamed,et al. B cell receptor editing in tolerance and autoimmunity. , 2007, Frontiers in bioscience : a journal and virtual library.
[43] H. Ploegh,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003 .